Protara Therapeutics, Inc.
TARA· Nasdaq
TARAProtara Therapeutics, Inc.
Filed May 8, 2025 · 10-Q · 38 days after period end · 0001213900-25-040811
| Metric | Q1 2025 | Q1 2024 | Q1 2023 | Q1 2022 |
|---|---|---|---|---|
| Net Income | -$11.91M | -$11.10M | -$9.05M | -$10.76M |
| EPS Diluted | -$0.29 | -$0.97 | -$0.80 | -$0.96 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Protara Therapeutics, Inc. · CIK 1359931 · Engraved from SEC EDGAR
ended Mar 31, 2025 · filed May 8, 2025 · 38 d after period end
